On July 9, PT.Vitanova Medika Indonesia, the second local Indonesian company under Sunrise, held its grand opening ceremony. This marks a key milestone in Sunrise’s deepened localization strategy in Indonesia. Equipped with an expanded service portfolio, the company will deliver integrated medical solutions to support the development of local healthcare.

As Sunrise’s second local platform in Indonesia, PT.Vitanova Medika Indonesia expands its service scope based on existing business lines. Its services cover full-range medical device supply, AKL/CDAKB registration, local regulatory consulting, OEM local manufacturing, laboratory turnkey projects, clinical academic cooperation and supply chain management, forming a closed-loop service system including product sourcing, regulatory compliance, delivery and after-sales support.

Driven by the expansion of Indonesia’s healthcare sector, local medical institutions have growing demands for compliant product launch, stable supply and local technical support. Rooted in Indonesia, PT.Vitanova Medika Indonesia complies with local regulatory requirements and clinical needs, streamlining the whole workflow from product introduction, registration to delivery and after-sales service, and providing one-stop medical support for public hospitals, private medical groups and local distributors.

The launch of this new entity is an important milestone of Sunrise’s long-term investment in Indonesia. Since entering the Indonesian market, Sunrise has built bridges connecting Chinese and Indonesian medical industries and established local entities step by step. PT.Vitanova Medika Indonesia will work synergistically with other group platforms to enrich service offerings and deliver faster, more flexible local support for partners.

Going forward, PT.Vitanova Medika Indonesia will adhere to rigorous compliance standards, continuously optimize products and services, introduce high-quality minimally invasive, interventional and endoscopic medical devices, and strengthen cooperation with Indonesian medical institutions and industry partners. It will help improve accessible healthcare in Indonesia and contribute to the growth of the medical industry across Southeast Asia.